BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1987290)

  • 41. Anti-endomysial antibodies. A serologic marker of dermatitis herpetiformis.
    Accetta P; Kumar V; Beutner EH; Chorzelski TP; Helm F
    Arch Dermatol; 1986 Apr; 122(4):459-62. PubMed ID: 3513713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating IgA anti-basement membrane zone antibodies in dermatitis herpetiformis.
    Yaoita H; Katz SI
    J Invest Dermatol; 1977 Dec; 69(6):558-60. PubMed ID: 336800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis.
    Preisz K; Sárdy M; Horváth A; Kárpáti S
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):74-9. PubMed ID: 15649195
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dermatitis herpetiformis: preparation of papillary dermis and the effect of proteolytic enzymes on the IgA deposits.
    Egelrud T; Bäck O
    J Invest Dermatol; 1984 May; 82(5):501-5. PubMed ID: 6392432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dermatitis herpetiformis: biochemical properties of the granular deposits of IgA in papillary dermis. Characterization of SDS-soluble IgA-like material and potentially antigen-binding IgA fragments released by pepsin.
    Egelrud T; Bäck O
    J Invest Dermatol; 1985 Apr; 84(4):239-45. PubMed ID: 3920330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [IgA deposits on the formalin-fixed, paraffin-embedded skin section of a patient with dermatitis herpetiformis by means of the PAP technique].
    Hayashi M; Sugimoto K; Sonoda T; Nakajima H; Nagai R
    Nihon Hifuka Gakkai Zasshi; 1984 Mar; 94(3):261-3. PubMed ID: 6381817
    [No Abstract]   [Full Text] [Related]  

  • 47. Ultrastructural binding sites of endomysium antibodies from sera of patients with dermatitis herpetiformis and coeliac disease.
    Kárpáti S; Meurer M; Stolz W; Bürgin-Wolff A; Braun-Falco O; Krieg T
    Gut; 1992 Feb; 33(2):191-3. PubMed ID: 1541414
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IgA-binding structures in dermatitis herpetiformis skin are independent of elastic-microfibrillar bundles.
    Lightner VA; Sakai LY; Hall RP
    J Invest Dermatol; 1991 Jan; 96(1):88-92. PubMed ID: 1987301
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic bullous disease of childhood and linear IgA disease of adults are IgA1-mediated diseases.
    Wojnarowska F; Bhogal BS; Black MM
    Br J Dermatol; 1994 Aug; 131(2):201-4. PubMed ID: 7917982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IgA antibodies against reticulin and endomysium in the serum and gastrointestinal secretions of patients with dermatitis herpetiformis.
    McCord ML; Hall RP
    Dermatology; 1994; 189 Suppl 1():60-3. PubMed ID: 8049567
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dermatitis herpetiformis. Cutaneous deposition of polyclonal IgA1.
    Olbricht SM; Flotte TJ; Collins AB; Chapman CM; Harrist TJ
    Arch Dermatol; 1986 Apr; 122(4):418-21. PubMed ID: 3082293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alternate-pathway complement fixation by IgA in the skin in dermatitis herpetiformis.
    Seah PP; Fry L; Mazaheri MR; Mowbray JF; Hoffbrand AV; Holborow EJ
    Lancet; 1973 Jul; 2(7822):175-7. PubMed ID: 4124252
    [No Abstract]   [Full Text] [Related]  

  • 53. Dermatitis herpetiformis and IgA.
    Rogers RS
    J Invest Dermatol; 1978 Sep; 71(3):224. PubMed ID: 690487
    [No Abstract]   [Full Text] [Related]  

  • 54. Linear IgA bullous dermatosis clinically simulating pemphigus vulgaris.
    Tanita Y; Masu S; Kato T; Tagami H
    Arch Dermatol; 1986 Mar; 122(3):246-8. PubMed ID: 3954389
    [No Abstract]   [Full Text] [Related]  

  • 55. [Dermatitis herpetiformis].
    Teillac D
    Ann Dermatol Venereol; 1989; 116(8):571-4. PubMed ID: 2688517
    [No Abstract]   [Full Text] [Related]  

  • 56. IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis and pediatric celiac disease.
    Jaskowski TD; Hamblin T; Wilson AR; Hill HR; Book LS; Meyer LJ; Zone JJ; Hull CM
    J Invest Dermatol; 2009 Nov; 129(11):2728-30. PubMed ID: 19516268
    [No Abstract]   [Full Text] [Related]  

  • 57. IgA in dermatitis herpetiformis.
    van der Meer JB
    Neth J Med; 1988 Aug; 33(1-2):48. PubMed ID: 3247009
    [No Abstract]   [Full Text] [Related]  

  • 58. Dermatitis herpetiformis.
    Fry L; Seah PP; Hoffbrand AV
    Clin Gastroenterol; 1974 Jan; 3(1):145-57. PubMed ID: 4599262
    [No Abstract]   [Full Text] [Related]  

  • 59. Circulating reticulin autoantibodies of IgA class in dermatitis herpetiformis.
    Ljunghall K; Scheynius A; Forsum U
    Br J Dermatol; 1979 Feb; 100(2):173-6. PubMed ID: 371658
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IgA in dermatitis-herpetiformis skin is dimeric.
    Unsworth DJ; Payne AW; Leonard JN; Fry L; Holborow EJ
    Lancet; 1982 Feb; 1(8270):478-9. PubMed ID: 6121142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.